Plasma exchange for acute optic neuritis in neuromyelitis optica or neuromyelitis optica spectrum disorder: a systematic review

References

• Wuebbolt D, Andrejevic K, Nguyen V, et al. Pregnancy outcomes in patients with neuromyelitis optica. Obstetr Gynecol. 2018;131(1):1–11. doi: 10.1097/01.AOG.0000533052.44223.2d.
   Google Scholar
• Sellner J, Boggild M, Clanet M, et al. EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol. 2010;17(8):1019–1032. doi: 10.1111/j.1468-1331.2010.03066.x.
   PubMed Web of Science ®Google Scholar
• Yamagami A, Wakakura M, Inoue K, et al. Clinical characteristics of anti-aquaporin 4 antibody positive optic neuritis in Japan. Neuroophthalmology. 2019;43(2):71–80. doi: 10.1080/01658107.2018.1520905.
   PubMed Web of Science ®Google Scholar
• Song W, Qu Y, Huang X. Plasma exchange: an effective add-on treatment of optic neuritis in neuromyelitis optica spectrum disorders. Int Ophthalmol. 2019;39(11):2477–2483. doi: 10.1007/s10792-019-01090-z.
   PubMed Web of Science ®Google Scholar
• Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177–189. doi: 10.1212/WNL.0000000000001729.
   PubMed Web of Science ®Google Scholar
• Hickman SJ, Ko M, Chaudhry F, et al. Optic neuritis: an update typical and atypical optic neuritis. Neuro-ophthalmology. 2008;32(5):237–248. doi: 10.1080/01658100802391905.
   Web of Science ®Google Scholar
• Levin MH, Bennett JL, Verkman AS. Optic neuritis in neuromyelitis optica. Prog Retin Eye Res. 2013;36:159–171. doi: 10.1016/j.preteyeres.2013.03.001.
   PubMed Web of Science ®Google Scholar
• Likhar N, Mothe RK, Esam H, et al. Epidemiology and current treatment of neuromyelitis optica: a systematic review. Value in Health. 2015;18(7):A750–A751. doi: 10.1016/j.jval.2015.09.2904.
   Web of Science ®Google Scholar
• McGuinness LA, Higgins JP. Risk of bias VISualization (robvis): An R package and shiny web app for visualizing risk of bias assessments. Res Synth Methods. 2021;12(1):55–61. doi: 10.1002/jrsm.1411.
   PubMed Web of Science ®Google Scholar
• Bonnan M, Valentino R, Debeugny S, et al. Short delay to initiate plasma exchange is the strongest predictor of outcome in attacks of neuromyelitis optica spectrum disorders. J Neurol Neurosurg Psychiatry. 2018;89(4):346–351. doi: 10.1136/jnnp-2017-316286.
   PubMed Web of Science ®Google Scholar
• Aungsumart S, Apiwattanakul M. Clinical outcomes and predictive factors related to good outcomes in plasma exchange in severe attack of NMOSD and long extensive transverse myelitis: case series and review of the literature. Mult Scler Relat Disord. 2017;13:93–97. doi: 10.1016/j.msard.2017.02.015.
   PubMed Web of Science ®Google Scholar
• Songthammawat T, Srisupa-Olan T, Siritho S, et al. A pilot study comparing treatments for severe attacks of neuromyelitis optica spectrum disorders: intravenous methylprednisolone (IVMP) with add-on plasma exchange (PLEX) versus simultaneous ivmp and PLEX. Mult Scler Relat Disord. 2020;38:101506. doi: 10.1016/j.msard.2019.101506.
   PubMed Web of Science ®Google Scholar
• Merle H, Olindo S, Jeannin S, et al. Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica. Arch Ophthalmol. 2012;130(7):858–862. doi: 10.1001/archophthalmol.2012.1126.
   PubMedGoogle Scholar
• Trebst C, Reising A, Kielstein JT, et al. Plasma exchange therapy in Steroid-Unresponsive relapses in patients with multiple sclerosis. Blood Purif. 2009;28(2):108–115. doi: 10.1159/000224630.
   PubMed Web of Science ®Google Scholar
• Roesner S, Appel R, Gbadamosi J, et al. Treatment of steroid-unresponsive optic neuritis with plasma exchange. Acta Neurol Scand. 2012;126(2):103–108. doi: 10.1111/j.1600-0404.2011.01612.x.
   PubMed Web of Science ®Google Scholar
• Koziolek M, Mühlhausen J, Friede T, et al. Therapeutic apheresis in pediatric patients with acute CNS inflammatory demyelinating disease. Blood Purif. 2013;36(2):92–97. doi: 10.1159/000354077.
   PubMed Web of Science ®Google Scholar
• Deschamps R, Gueguen A, Parquet N, et al. Plasma exchange response in 34 patients with severe optic neuritis. J Neurol. 2016;263(5):883–887. doi: 10.1007/s00415-016-8073-8.
   PubMed Web of Science ®Google Scholar
• Mori S, Kurimoto T, Ueda K, et al. Short-term effect of additional apheresis on visual acuity changes in patients with steroid-resistant optic neuritis in neuromyelitis optica spectrum disorders. Jpn J Ophthalmol. 2018;62(4):525–530. doi: 10.1007/s10384-018-0602-9.
   PubMed Web of Science ®Google Scholar
• Lipphardt M, Mühlhausen J, Kitze B, et al. Immunoadsorption or plasma exchange in steroid-refractory multiple sclerosis and neuromyelitis optica. J Clin Apher. 2019;34(4):381–391. doi: 10.1002/jca.21686.
   PubMed Web of Science ®Google Scholar
• Savransky A, Rubstein A, Rios MH, et al. Prognostic indicators of improvement with therapeutic plasma exchange in pediatric demyelination. Neurology. 2019;93(22):e2065–e2073. doi: 10.1212/WNL.0000000000008551.
   PubMed Web of Science ®Google Scholar
• Flanagan EP, Cabre P, Weinshenker BG, et al. Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum. Ann Neurol. 2016;79(5):775–783. doi: 10.1002/ana.24617.
   PubMed Web of Science ®Google Scholar
• Wei S. Effectiveness of Plasma Exchange in Treating with Severe Acute AQP4-Ab Positive Optic Neuritis. 2018; NCT03586557: https://clinicaltrials.gov/show/NCT03586557.
   Google Scholar